Heron Therapeutics Inc (NASDAQ:HRTX)

31.15
Delayed Data
As of 4:00pm ET
 +1.30 / +4.36%
Today’s Change
12.70
Today|||52-Week Range
32.70
+72.10%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close29.85
Today’s open29.85
Day’s range29.85 - 31.35
Volume1,061,293
Average volume (3 months)1,245,830
Market cap$1.5B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+20.05%
Earnings growth (this year)+30.24%
Earnings growth (next 5 years)+47.80%
Revenue growth (last year)+2,305.55%
P/E ratioNM
Price/Sales31.79
Price/Book11.21

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc-0.15-2.11%
BYSIBeyondspring Inc+3.60+13.09%
ZIOPZIOPHARM Oncology In...+0.03+0.70%
TGTXTG Therapeutics Inc-0.30-2.04%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 11, 2018
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$30.8M
Annual profit (last year)-$197.5M
Net profit margin-641.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts